Singular Genomics Systems Inc. (OMIC) announced that it has received a non-binding proposal from Deerfield Management Company, L.P. and certain affiliated funds, to acquire all of the Company's outstanding shares of common stock that are not already owned by Deerfield for $10.00 per share in cash. OMIC closed Thursday's regular trading at $5.65 up $0.15 or 2.73%.

Singular Genomics Systems Inc.（OMIC）宣布，已收到Deerfield Management Company，L.P.和某些附属基金的无约束力提案，以每股10.00美元的现金收购Deerfield尚未拥有的公司所有已发行普通股。OMIC周四常规交易收于5.65美元，上涨0.15美元，涨幅2.73%。

In the after-hours trading the stock further gained $3.81 or 67.43%.According to the company, Deerfield, an existing stockholder of the Company, indicated in its letter that it intends to invite other major stockholders and existing management to rollover their shares of common stock into the new company..

在盘后交易中，该股进一步上涨3.81美元，涨幅67.43%。据该公司称，该公司现有股东迪尔菲尔德在信中表示，它打算邀请其他大股东和现有管理层将其普通股股份转为新公司。。

Singular Genomics said that the company and the Special Committee do not intend to comment further about Deerfield's proposal unless and until the Special Committee deems further disclosure is appropriate. For comments and feedback contact: editorial@rttnews.comBusiness News

Singular Genomics表示，除非特别委员会认为进一步披露是适当的，否则该公司和特别委员会不打算对迪尔菲尔德的提议发表进一步评论。如需评论和反馈，请联系：editorial@rttnews.comBusiness新闻

Biotech Stocks Facing FDA Decision In April 2024

2024年4月美国食品和药物管理局决定生物技术股